Quality Control for DG Gel Systems
Reference Description Storage Components System compatibility Presentation
Essential II Control          
213287 For ABO/Rh(D) grouping, determination of the Rh phenotype and K antigen and screening of irregular antibodies Stable for a minimum of 35 days after delivery when stored at 2-8°C
  • Tube 1: A rr (ccddee), K pos with anti-B and anti-D (approximate 0.05 IU/mL)
  • Tube 2: B R1R2 (CcD.Ee), K neg, Fya neg with anti-A and anti-Fya
  • DG Gel system (manual or automated)
  • Grifols conventional techniques 
  • MDmulticard system
2 x 2 x 6 mL (0.2 fl oz)
Extended IV Control          
213286 For ABO/Rh(D) grouping, determination of the Rh phenotype and K antigen and screening of irregular antibodies (including the possible dosage effect and the detection of weak antibodies) Stable for a minimum of 35 days after delivery when stored at 2-8°C
  • Tube 1: A2B R1R2 (CcD.Ee), K pos
  • Tube 2: A R1w R1 (CCw Dee), Fya neg, with anti-B and anti-Fya
  • Tube 3: B R2R2 (ccD.EE), with anti-A
  • Tube 4: O rr (ccddee), K neg, with anti-A, anti-B and anti-D (approximate 0.05 IU/mL)
  • DG Gel system (manual or automated)
  • Grifols conventional techniques 
  • MDmulticard system
4 x 6 mL (0.2 fl oz)

This information is intended for physicians and healthcare professionals only.

Product registration and availability vary by country. For more information on product availability, please contact us here.